Detectable serum PSA after radical prostatectomy. Clinical and pathological relevance of perianastomotic biopsies

被引:0
|
作者
Minardi, D [1 ]
Galosi, AB [1 ]
Dell'Atti, L [1 ]
Yehia, M [1 ]
Muzzonigro, G [1 ]
机构
[1] Polytech Univ, Marche Med Sci, Inst Urol, Ancona, Italy
关键词
prostate specific antigen; radical prostatectomy; biochemical failure; perianastomotic biopsies; intraprostatic surgical margin;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Few reports have detailed the histopathological results of biopsies of the vesicourethral anastomosis or prostatic bed in patients with a detectable postoperative PSA. Patients and Methods: Among a series of 153 patients who underwent radical retropubic prostatectomies, we analyzed the results of 64 perianastomotic biopsies performed in 17 men with a detectable PSA and no evidence of local recurrence or distant metastases. Results: Fourteen of the 17 patients had a relapse of prostatic carcinoma; the results of histology in the three pT(2b)N(0)M(0) patients revealed the presence of benign prostatic hyperplasia in 2 patients and atypical cribriform proliferation in I patient. The first two patients are free from prostatic cancer recurrence 36 months after perianastomotic biopsies; a further biopsy performed 6 months after in the third patient showed the presence of prostatic carcinoma. Conclusion: The present study raises the possibility that residual benign tissue, resulting from unintentional disruption of the prostatic capsule during surgery, may be responsible for a detectable postoperative PSA. These cases comprise a histopathological classification described as "intraprostatic surgical margin".
引用
收藏
页码:1179 / 1185
页数:7
相关论文
共 50 条
  • [31] A phase II trial of celecoxib in PSA recurrent prostate cancer after definitive radiation therapy or radical prostatectomy.
    Pruthi, RS
    Derksen, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 405S - 405S
  • [32] Radiotherapy for PSA recurrence after radical prostatectomy
    Vanuytsel, L
    Janssens, G
    Van Poppel, H
    Rijnders, A
    Baert, L
    EUROPEAN UROLOGY, 2001, 39 (04) : 425 - 429
  • [33] URETHRAL PSA LEVELS AFTER RADICAL PROSTATECTOMY
    Pejcic, T. P.
    Milkovic, B.
    Kajmakovic, B.
    Topuzovic, C.
    Kozomara, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 559 - 559
  • [34] Standardisation of PSA determination after radical prostatectomy
    HadziDjokic, J
    Micic, S
    Lalic, N
    Dzamic, Z
    Acimovic, M
    MajkicSingh, N
    Stojiljkovic, J
    5TH MEDITERRANEAN CONGRESS OF UROLOGY, 1997, : 169 - 173
  • [35] Urethral PSA production after radical prostatectomy
    Pejcic, T.
    Lalic, N.
    Glisic, B.
    Tulic, C.
    Milkovic, B.
    Hadzi-Djokic, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (08) : 637 - 638
  • [36] Radiotherapy in PSA recurrence after radical prostatectomy
    Neu, B
    Hütenschmidt, B
    Sautter-Bihl, ML
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 5 - 5
  • [37] Natural history of an immediately detectable PSA following radical prostatectomy in a contemporary cohort
    Lonergan, Peter E.
    Cowan, Janet E.
    Washington, Samuel L., III
    Greenberg, Scott A.
    Nguyen, Hao G.
    Carroll, Peter R.
    PROSTATE, 2021, 81 (13): : 1009 - 1017
  • [38] Clinicopathological features predictive of biochemical (PSA) progression following radical prostatectomy. A study in Brazil
    Noronha, M.
    Meirelles, L.
    Freitas, L.
    Magna, L.
    Ferreira, U.
    Billis, A.
    HISTOPATHOLOGY, 2008, 53 : 283 - 283
  • [39] PATHOLOGICAL FINDINGS AND PSA OUTCOMES AFTER LAPAROSCOPIC RADICAL PROSTATECTOMY FOR HIGH RISK PROSTATE CANCER
    Ploussard, G.
    Salomon, L.
    Allory, Y.
    Terry, S.
    Vordos, D.
    Hoznek, A.
    Vacherot, F.
    Abbou, C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 226 - 227
  • [40] Multiple vesico-urethral biopsies following radical prostatectomy: The predictive roles of TRUS, DRE, PSA and the pathological stage
    Scattoni, V
    Roscigno, M
    Raber, M
    Montorsi, F
    Da Pozzo, L
    Guazzoni, G
    Freschi, M
    Rigatti, P
    EUROPEAN UROLOGY, 2003, 44 (04) : 407 - 414